The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Cited by (426)

Items 201–300 of 426

1. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis
   Fanny Lalloyer, Denis A. Mogilenko, An Verrijken, Joel T. Haas, Antonin Lamazière, Mostafa Kouach, Amandine Descat, Sandrine Caron, Emmanuelle Vallez, Bruno Derudas et al. · 2023 · Journal of Hepatology
2. Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD
   María Victoria Fernández-Cantos, Diego García-Morena, Valeria Iannone, Hani S El-Nezami, Marjukka Kolehmainen, Oscar Paul Kuipers · 2021 · Tissue Barriers
3. Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease
   Yuhua Gao, Jun Lin, Chuan Ye, Siqi Guo, Changtao Jiang · 2023 · Liver Research
4. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis
   Yi Luo, Benjamin E. Decato, Edgar D. Charles, Diane E. Shevell, Colleen A. McNaney, Petia A. Shipkova, Abraham Apfel, Giridhar Tirucherai, Arun Jayant Sanyal · 2021 · JHEP Reports
5. Multispecies probiotics complex improves bile acids and gut microbiota metabolism status in an in vitro fermentation model
   Wei Liu, Zhongxia Li, Xiaolei Ze, Chaoming Deng, Shunfu Xu, Feng Ye · 2024 · Frontiers in Microbiology
6. Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
   Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner · 2025 · Hepatology
7. Multi‐omics analysis of hiPSCs‐derived HLCs matured on‐chip revealed patterns typical of liver regeneration
   Mathieu Danoy, Yannick Tauran, Stéphane Poulain, Rachid Jellali, Johanna Bruce, Marjorie Leduc, Morgane Le Gall, Françoise Gilard, Taketomo Kido, Hiroshi Arakawa et al. · 2021 · Biotechnology and Bioengineering
8. Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition
   Junichi Iwamoto, Akira Honda, Teruo Miyazaki, Tadakuni Monma, Hajime Ueda, Yukio Morishita, Shoichiro Yara, Takeshi Thomas Hirayama, Tadashi Ikegami · 2021 · Hepatology Communications
9. Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
   Eunju Park, Jin‐Ju Jeong, Sung‐Min Won, Satya Priya Sharma, Yoseph Asmelash Gebru, Raja Ganesan, Haripriya Gupta, Ki Tae Suk, Dong Joon Kim · 2021 · Cells
10. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
    Tingfeng Wu, Junzhao Ye, Congxiang Shao, Fuxi Li, Yansong Lin, Qianqian Ma, Wei Wang, Shi‐Ting Feng, Bihui Zhong · 2021 · Frontiers in Endocrinology
11. Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
    Xiaolei Miao, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen · 2023 · Lipids in Health and Disease
12. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research
    Aline Gottlieb, Wesal Mosthael, Jan‐Peter Sowa, Ali E. Canbay · 2018 · Digestion
13. Bile-ology: from bench to bedside
    Lihua Jin, Zhipeng Fang, Min-jie Fan, Wendong Huang · 2019 · Journal of Zhejiang University SCIENCE B
14. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Saleh Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre Soares Rosado, Consolato Maria Sergi · 2024 · Biomedicines
15. The bile acid profile
    Zhenhua Liu, Chongge You · 2024 · Clinica Chimica Acta
16. Transporter Activity Changes in Nonalcoholic Steatohepatitis: Assessment with Plasma Coproporphyrin I and III
    Sagnik Chatterjee, Sambuddho Mukherjee, L.V.J. Sankara Sivaprasad, Tanvi Naik, Shashyendra Singh Gautam, Bokka Venkata Murali, Avinash A. Hadambar, Gowtham Raj Gunti, Vijaykumar Kuchibhotla, Avisek Deyati et al. · 2020 · Journal of Pharmacology and Experimental Therapeutics
17. Antarctic krill peptide alleviates liver fibrosis via downregulating the secondary bile acid mediated NLRP3 signaling pathway
    Hao Yue, Yanqi Li, Weizhen Cai, Xiaolin Bai, Ping Dong, Jingfeng Wang · 2022 · Food & Function
18. The emerging significance of mitochondrial targeted strategies in NAFLD treatment
    Tao Zhang, Yingli Nie, Jiliang Wang · 2023 · Life Sciences
19. A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
    Sisi Yan, Sha Liu, Jianyu Qu, Xiaowen Li, Jiahao Hu, Linyu Zhang, Xiangyan Liu, Xin Li, Xianglin Wang, Lixin Wen et al. · 2022 · Nutrients
20. Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
    Yifei Lu, Mingmei Shao, Caiyun Zhang, Hongjiao Xiang, Junmin Wang, Tao Wu, Guang Ji · 2022 · Frontiers in Pharmacology
21. Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD+/SIRT1 axis
    Na Yang, Runbin Sun, Xiaoli Zhang, Jing Wang, Lulu Wang, Huaijun Zhu, Man Yuan, Yifan Xu, Chun Ge, Jun Bao He et al. · 2023 · Biomedicine & Pharmacotherapy
22. Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti‐inflammation capacity
    Yongli Han, Lingling Luo, Hongli Li, Lijun Zhang, Yingxuan Yan, Minglv Fang, Jing Yu, Xiaoyan Gao, Ying Liu, Cheng Huang et al. · 2023 · BioFactors
23. Bile Acids, Gut Microbiome and the Road to Fatty Liver Disease
    Phillip B. Hylemon, Lianyong Su, Po‐Cheng Zheng, Jasmohan Singh Bajaj, Huiping Zhou · 2021 · Comprehensive physiology
24. Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review
    Roberta Forlano, Mathuri Sivakumar, Benjamin Harvey Mullish, Pinelopi Manousou · 2022 · International Journal of Molecular Sciences
25. RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression
    Yanyan Wang, Yunling Tai, Grayson W. Way, Jing Zeng, Derrick Zhao, Lianyong Su, Xixian Jiang, Kaitlyn G. Jackson, Xuan Wang, Emily C. Gurley et al. · 2022 · Cell & Bioscience
26. Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis
    Thoetchai Bee Peeraphatdit, Douglas Alano Simonetto, Vijay H. Shah · 2018 · Journal of Hepatology
27. Acute fatty liver of pregnancy and concomitant medical conditions: A review of cases at a quaternary obstetric hospital
    Annabelle Lamprecht, Adam Morton, Josephine Gwyneth Laurie, Winnifred Lee · 2018 · Obstetric Medicine
28. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice
    Carmen Rubio, Marta Puerto, Juan José García‐Rodríguez, Van B. Lu, Irma García‐Martinez, Rosa Alén, Patricia Sanmartín-Salinas, M. Val Toledo-Lobo, Jorge Sáiz, Francisco Javier Rupérez et al. · 2020 · Molecular Metabolism
29. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina · 2020 · SAGE Open Medicine
30. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice
    Ryo Yamauchi, Hidetoshi Takedatsu, Keiji Yokoyama, Eri Yamauchi, Motoko Kawashima, Takahiro Nagata, Yotaro Uchida, Takanori Kitaguchi, Tomotaka Higashi, Hiromi Fukuda et al. · 2021 · Hepatology International
31. Influence of a Biotechnologically Produced Oyster Mushroom (Pleurotus sajor-caju) on the Gut Microbiota and Microbial Metabolites in Obese Zucker Rats
    Garima Maheshwari, Denise K. Geßner, Klaus Neuhaus, Erika Most, Holger Zorn, Klaus Eder, Robert Ringseis · 2021 · Journal of Agricultural and Food Chemistry
32. Liver–gut axis signaling regulates circadian energy metabolism in shift workers
    Zhenning Yang, Helmut Zarbl, Bo Kong, Rulaiha E. Taylor, Kathleen Black, Howard M. Kipen, Veronia Basaly, Mingzhu Fang, Grace Liejun Guo · 2024 · The FASEB Journal
33. Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease
    Ting Zhou, Ziwen Jin, Rilei Jiang, Weiwei Li · 2025 · Frontiers in Pharmacology
34. Bile acid profiles in neonatal intrahepatic cholestasis caused by citrin deficiency
    Ching-Hsuan Yang, Chiung‐Yu Chen, Yen‐Yin Chou, Hung‐Chih Chiu, Wei-Lun Tsai, Shu‐Chu Shiesh · 2017 · Clinica Chimica Acta
35. A Dual Coverage Monitoring of the Bile Acids Profile in the Liver–Gut Axis throughout the Whole Inflammation-Cancer Transformation Progressive: Reveal Hepatocellular Carcinoma Pathogenesis
    Luwen Xing, Yiwen Zhang, Saiyu Li, Minghui Tong, Kaishun Bi, Qian Zhang, Qing Li · 2023 · International Journal of Molecular Sciences
36. Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
    Josh Bilson, Eleonora Scorletti, Jonathan Richard Swann, Christopher D. Byrne · 2024 · Biomolecules
37. New drug therapies for metabolic dysfunction-associated steatohepatitis
    John Y.L. Chiang · 2025 · Liver Research
38. Dietary fat composition shapes bile acid metabolism and severity of liver injury in a pig model of pediatric NAFLD
    Rodrigo Manjarín, Kayla Dillard, Morgan J. Coffin, Gabriella V. Hernandez, Victoria A. O. Smith, Trista Noland-Lidell, Tanvi R. Gehani, Hayden J. Smart, Kevin Wheeler, Kimberly A. Sprayberry et al. · 2022 · American Journal of Physiology-Endocrinology and Metabolism
39. Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice
    Ting Zhai, Junjun Wang, Yong Chen · 2023 · Scientific Reports
40. Inflammatory liver diseases and susceptibility to sepsis
    Hong Lü · 2024 · Clinical Science
41. Quantification of common and planar bile acids in tissues and cultured cells
    Stephanie J. Shiffka, Jace W. Jones, Linhao Li, Ann M. Farese, Thomas J. MacVittie, Hongbing Wang, Peter W. Swaan, Maureen A. Kane · 2020 · Journal of Lipid Research
42. Circulating Bile Acid Profiles: A Need for Further Examination
    Qi Li, Yu Tian, Yongsheng Chen · 2021 · The Journal of Clinical Endocrinology & Metabolism
43. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
    Himani Pandey, Prabudh Goel, Varunvenkat M. Srinivasan, Daryl W. T. Tang, Sunny H Wong, Devi Lal · 2025 · World Journal of Hepatology
44. Bile acids in liver and gastrointestinal cancer
    María Jesús Monte, Laura Fàbrega, Marta R. Romero, Álvaro G. Temprano, Neil Kaplowitz, Carmen García‐Ruiz, José J.G. Marı́n, José Carlos Fernández-Checa · 2025 · Seminars in Cancer Biology
45. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors
    Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon C. Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel E. Lefever, Xiang Li, Celeste E. Reese, Erin E. Kershaw et al. · 2021 · Experimental Biology and Medicine
46. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery
    José Ignacio Martínez‐Montoro, Mohammad Shafi Kuchay, Andrés Balaguer Román, María Antonia Martínez‐Sánchez, María Dolores Frutos, José Carlos Fernández‐García, Bruno Ramos‐Molina · 2021 · Obesity Reviews
47. NTCP Deficiency Affects the Levels of Circulating Bile Acids and Induces Osteoporosis
    Fangji Yang, Wenxiong Xu, Lina Wu, Luo Yang, Shu Zhu, Lu Wang, Wenbin Wu, Yuzhen Zhang, Yutian Chong, Liang Peng · 2022 · Frontiers in Endocrinology
48. Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice
    Wei J. Wang, Ting Zhai, Ping Luo, Xiaolei Miao, Junjun Wang, Yong Chen · 2023 · Frontiers in Nutrition
49. Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics
    Saori Shoji, Masamitsu Maekawa, Jiro Ogura, Toshihiro Sato, Nariyasu Mano · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
50. The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
    Siwen Shen, Yao Liu, Nuoya Wang, Zhenhe Huang, Guifang Deng · 2025 · Frontiers in Microbiology
51. The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients
    Charlotte Wilhelmina Wernberg, Kim Ravnskjær, Mette Munk Lauridsen, Maja Sofie Thiele · 2021 · Journal of Clinical Medicine
52. Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling
    Yang Xie, Feng Shen, Yafang He, Can‐Jie Guo, Rui‐Xu Yang, Haixia Cao, Qin Pan, Jian‐Gao Fan · 2023 · Nutrients
53. Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice
    Liming Liu, Liquan Deng, Wei Wei, Chunhua Li, Yuting Lu, Jieying Bai, Letian Li, Heping Zhang, Ningyi Jin, Chang Li et al. · 2023 · International Journal of Molecular Sciences
54. Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
    An-Na Moon, François Briand, Natália Martins Breyner, Dong Keun Song, Martin Rønn Madsen, Hongbin Kim, Keonwoo Choi, Yoonsuk Lee, Wan Namkung · 2024 · Biomedicine & Pharmacotherapy
55. A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH
    Justine Gillard, Martin Roumain, Corinne Picalausa, Morgane M. Thibaut, Laure‐Alix Clerbaux, Anne Tailleux, Bart Staels, Giulio G. Muccioli, Laure B. Bindels, Isabelle A. Leclercq · 2024 · JHEP Reports
56. Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition
    Kylynda C. Bauer, Kelsey E. Huus, Eric Brown, Tahereh Bozorgmehr, Charisse Petersen, Mihai S. Cirstea, Sarah E. Woodward, J. McCoy, Jeong Ki Hun, Reinald Pamplona et al. · 2020 · mSystems
57. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis
    Sayuri Takada, Tsutomu Matsubara, Hideki Fujii, Misako Sato-Matsubara, Atsuko Daikoku, Naoshi Odagiri, Yuga Amano‐Teranishi, Norifumi Kawada, Kazuo Ikeda · 2020 · Laboratory Investigation
58. Anti‐TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut‐derived hormones and metabolic status
    Paul Peter Manka, Svenja Sydor, Nishikant V Wase, Jan Best, Malte Brandenburg, A Hellbeck, Julia Schänzer, Ramiro Vilchez‐Vargas, Alexander Link, Anja Figge et al. · 2021 · Liver International
59. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis
    Vik Meadows, Corinn N. Marakovits, Burcin Ekser, Debjyoti Kundu, Tianhao Zhou, Konstantina Kyritsi, Linh Pham, Lixian Chen, Lindsey Leann Kennedy, Ludovica Ceci et al. · 2022 · American Journal of Physiology-Gastrointestinal and Liver Physiology
60. Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
    Chance S. Friesen, Chelsea M. Hosey, Sherwin S. Chan, Iván L. Csanaky, Jonathan B. Wagner, Brooke R. Sweeney, Alec Friesen, Jason D. Fraser, Valentina Shakhnovich · 2021 · Frontiers in Endocrinology
61. Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities
    Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip B. Hylemon · 2026 · Pharmacological Reviews
62. Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH)
    Mirjana Grocic, Madison Nguyen, Arun Jayant Sanyal · 2026 · Diabetes Obesity and Metabolism
63. Deletion of hepatic growth hormone receptor (GHR) alters the mouse gut microbiota by affecting bile acid metabolism
    Zichao Yu, Yu Wang, Fang Zhang, Rui Ma, Xiaoyu Yang, Kun Yang, Ai Mi, Liyuan Ran, Yingjie Wu · 2023 · Gut Microbes
64. Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C–related liver disease
    Rabab Ali, James A. Haddad, Gabriella M. Quinn, Grace Y. Zhang, Elizabeth C. Townsend, Lisa Scheuing, Kareen L. Hill, Matthew G Menkart, Jenna L Oringher, Regina Umarova et al. · 2024 · Hepatology Communications
65. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
    Hao CHEN, Yang Zhou, Haiping Hao, Jing XIONG · 2024 · Chinese Journal of Natural Medicines
66. Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis
    Martina Montagnana, Elisa Danese, Alice Giontella, Sara Bonafini, Marco Benati, Angela Tagetti, Andrea Dalbeni, Paolo Cavarzere, Rossella Gaudino, Mairi Pucci et al. · 2020 · Diagnostics
67. Free Cholesterol Affects the Function and Localization of Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) and Organic Cation Transporter 1 (OCT1)
    Jessica Y. Idowu, Bruno Hagenbuch · 2022 · International Journal of Molecular Sciences
68. Translational characterization of the temporal dynamics of metabolic dysfunctions in liver, adipose tissue and the gut during diet-induced NASH development in Ldlr−/−.Leiden mice
    Eveline Gart, Wim van Duyvenvoorde, Jessica M. Snabel, Christa de Ruiter, Joline Attema, Martien P. M. Caspers, Serene Lek, Bertie Joan van Heuven, Arjen G. C. L. Speksnijder, Martin A. Giera et al. · 2023 · Heliyon
69. Circulating bile acid profiles in Japanese patients with NASH
    Shoichiro Yara, Tadashi Ikegami, Teruo Miyazaki, Masashi Murakami, Junichi Iwamoto, Takeshi Thomas Hirayama, Motoyuki Kohjima, Makoto Nakamuta, Akira Honda · 2019 · GastroHep
70. Molecular mechanisms of non-alcoholic fatty liver disease development
    Tatyana S. Sall, Elena S. Shcherbakova, Stanislav I. Sitkin, Timur Vakhitov, Игорь Геннадьевич Бакулин, Elena V. Demyanova · 2021 · Russian Journal of Preventive Medicine
71. Bile salt hydrolase: a key player in gut microbiota and its implications for metabolic dysfunction-associated steatotic liver disease
    Weixing Zhao, Huiying Wang, Minghua Zheng, Yan Ni · 2025 · Microbiome Research Reports
72. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
    Yufang Ding, Karin Yanagi, Fang Yang, Evelyn S. Callaway, Clint Cheng, Martha E. Hensel, Rani Menon, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2024 · eLife
73. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
    Ernesto Saenz, Nathally Espinosa Montagut, Baohong Wang, Christoph K. Stein-Thöringer, Kaicen Wang, Honglei Weng, Matthias P. Ebert, Kai Markus Schneider, Lanjuan Li, Andreas Teufel · 2024 · Engineering
74. Chlordecone-induced hepatotoxicity and fibrosis are mediated by the proteasomal degradation of septins
    Thibaut Léger, Sarah Alilat, Pierre‐Jean Ferron, Léonie Dec, Tahar Bouceba, Rachelle Lanceleur, Sylvie Huet, Yoann Devriendt-Renault, Julien Parinet, Bruno Clément et al. · 2024 · Journal of Hazardous Materials
75. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Salim Maher, Jayashi Rajapakse, Emad M. El-Omar, Amany Zekry · 2024 · Seminars in Liver Disease
76. Disentangling Organ‐Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism
    Tingting Li, Chenyang Fu, Zhongzheng Tang, Changkun Li, Duanyi Hua, Bei Liu, Zheying Tao, Jie Yang, Li Zhang, Tingting Cheng et al. · 2025 · Liver International
77. Differential Effects of Dietary White Meat and Red Meat on NAFLD Progression by Modulating Gut Microbiota and Metabolites in Rats
    Juan Li, Yuting Li, Shufen Feng, Kaiyin He, Liliangzi Guo, Weiwei Chen, Min Wang, Lixian Zhong, Chutian Wu, Xiaojuan Peng et al. · 2022 · Oxidative Medicine and Cellular Longevity
78. A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
    Yi Zang, Jingjing Shi, Guanguan Zhao, Bixi Tang, Mingliang Liu, Benqiang Yao, Gaihong Wang, Hualing Pan, Shengsheng Yang, Rong Deng et al. · 2026 · Nature
79. Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome
    Saisai Zhang, Hau-Tak Chau, Hein Min Tun, Fung‐Yu Huang, Danny K.-H. Wong, Lung‐Yi Mak, Man‐Fung Yuen, Wai‐Kay Seto · 2024 · EBioMedicine
80. Ex vivo metabolism kinetics of primary to secondary bile acids via a physiologically relevant human faecal microbiota model
    Daniel Zhi Wei Ng, Adrian Low, Amanda Jia Hui Tan, Jia Hui Ong, Wit Thun Kwa, Jonathan Wei Jie Lee, Eric Chun Yong Chan · 2024 · Chemico-Biological Interactions
81. Altered bile acids profile is a risk factor for hyperandrogenism in lean women with PCOS: a case control study
    Yuchen Zhu, Siyu Lin, Yi Zhang, Jie Yu, JiaRong Fu, Yushan Li, Chang Shan, Jie Cai, Wei Xin Liu, Tao Tao · 2024 · Scientific Reports
82. High-fat/high-sucrose diet results in a high rate of MASH with HCC in a mouse model of human-like bile acid composition
    Hajime Ueda, Akira Honda, Teruo Miyazaki, Yukio Morishita, Takeshi Thomas Hirayama, Junichi Iwamoto, Tadashi Ikegami · 2024 · Hepatology Communications
83. Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota
    Shang Peng, Meng Moran, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen · 2025 · International Journal of Molecular Sciences
84. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors
    Tomonori Kamiya, Naoko Ohtani · 2022 · International Immunology
85. Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides
    Jonas M. McCaffrey, Jamal A. Ibdah · 2025 · Nutrients
86. Hepatic FOXA3 overexpression prevents Western diet–induced obesity and MASH through TGR5
    Raja Gopoju, Jiayou Wang, Xiaoli Pan, Shuwei Hu, Li Lin, Alyssa Clark, Yanyong Xu, Liya Yin, Xinwen Wang, Yanqiao Zhang · 2024 · Journal of Lipid Research
87. ABL1‒YAP1 axis in intestinal stem cell activated by deoxycholic acid contributes to hepatic steatosis
    Tiancheng Mao, Xianjun Xu, Leheng Liu, Yulun Wu, Xiaowan Wu, Wenlu Niu, Dandan You, Xiaobo Cai, Lungen Lu, Hui Jun Zhou · 2024 · Journal of Translational Medicine
88. Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis
    Aysun Yakut · 2025 · World Journal of Hepatology
89. Bile Acids, Gut Microbiome and the Road to Fatty Liver Disease
    Phillip B. Hylemon, Lianyong Su, Po‐Cheng Zheng, Jasmohan Singh Bajaj, Huiping Zhou · 2021 · Comprehensive physiology
90. Dysregulation of Bile Acids in Patients with NAFLD
    Xinmu Zhang, Ruitang Deng · 2019 · IntechOpen eBooks
91. Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
    Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Yuji Ogawa, Kento Imajo, Yusuke Saigusa, Koji Yamamoto, Takeharu Yamanaka et al. · 2020 · BMJ Open
92. Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD
    Magdalena A. Maj, Douglas G. Burrin, Rodrigo Manjarín · 2023 · Biomedicines
93. The interplay between host cellular and gut microbial metabolism in NAFLD development and prevention
    Simin Yu, Lei Xu · 2021 · Journal of Applied Microbiology
94. Amelioration of Alzheimer’s Disease by Gut-Pancreas-Liver-Brain Interaction in an App Knock-In Mouse Model
    Mayumi Minamisawa, Yuma Sato, Eitarou Ishiguro, Tetsuyuki Taniai, Taiichi Sakamoto, Gota Kawai, Takashi Saito, Takaomi C. Saido · 2021 · Life
95. Olive- and Coconut-Oil-Enriched Diets Decreased Secondary Bile Acids and Regulated Metabolic and Transcriptomic Markers of Brain Injury in the Frontal Cortexes of NAFLD Pigs
    Magdalena A. Maj, Tanvi R. Gehani, Chad E. Immoos, Mikaelah S. Medrano, Rob K. Fanter, Christine R. Strand, Hunter Glanz, Brian D. Piccolo, Mohammed Kotb Abo-Ismail, Michael R. La Frano et al. · 2022 · Brain Sciences
96. The future R&D landscape in non-alcoholic steatohepatitis (NASH)
    Darcey Black, Sarah Brockbank, Simon Cruwys, Kim Goldenstein, Peter Hein, Bob Humphries · 2018 · Drug Discovery Today
97. Mining Gut Microbiota From Bariatric Surgery for MAFLD
    Wei‐Kai Wu, Yi‐Hsun Chen, Po‐Chu Lee, Po‐Jen Yang, Chin‐Chen Chang, Kao‐Lang Liu, Cheng‐Chih Hsu, Chi‐Chang Huang, Hsiao-Li Chuang, Lee‐Yan Sheen et al. · 2021 · Frontiers in Endocrinology
98. Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
    Zhengyi Zhu, Yuyan Chen, Xueqian Qin, Shujun Liu, Jinglin Wang, Haozhen Ren · 2023 · Smart Medicine
99. Dynamic pattern of postprandial bile acids in paediatric non‐alcoholic fatty liver disease
    Jiating Huang, Hu Lin, A‐Na Liu, Wei Wu, Anna Alisi, Rohit Seth Loomba, Cuifang Xu, Wenqin Xiang, Jie Shao, Guanping Dong et al. · 2024 · Liver International
100. Transcriptomics, lipidomics, and single-nucleus RNA sequencing integration: exploring sphingolipids in MASH-HCC progression
     Jing Zeng, Grayson W. Way, Nan Wu, Xixian Jiang, Yunling Tai, Derrick Zhao, Lianyong Su, Qianhua Yan, Xuan Wang, Emily C. Gurley et al. · 2025 · Cell & Bioscience